BioWorld

Nov. 21, 2016

View Archived Issues

Money raised by biotech: Jan. 1 - Nov. 17, 2016

Money raised by biotech in 2016 vs. 2015

BioWorld stock report for public biotechnology companies

The week's biggest gainers and losers

Biopharmaceutical modified and terminated agreements: October 21 - November 17, 2016

Biopharmaceutical collaborations: October 21 - November 17, 2016

Top biopharmaceutical collaborations in 2016

Word on the street

Week in review

Week in Washington

Make sure you 'nose' how to take that drug

Intranasal drug delivery isn't just for stuffy noses. Multiple drugs delivered through the nose have been approved in the past year despite not treating diseases of the nose. Read More

Today's news in brief

BioWorld

BioWorld briefs for June 4, 2026.

ASCO 2026: A revolution in pancreatic cancer

BioWorld

At the 2026 American Society of Clinical Oncology (ASCO) Annual Meeting, Revolution Medicines Inc. followed up its stellar top-line data with the details from the...

News in brief

BioWorld Asia

BioWorld Asia briefs for June 2, 2026

EASL 2026: Emerging liver disease targets to watch

BioWorld

At the recently concluded European Association for the Study of the Liver meeting, presentations underscored how increasingly granular insights into liver...

Bispecific antibodies with heavy chain in green and pink, light chain in blue and yellow

ASCO 2026: PD-(L)1 x VEGF bispecifics fight it out

BioWorld

Multiple companies are chasing Akeso Inc. and Summit Therapeutics Inc. in the battle to potentially dethrone Keytruda (pembrolizumab, Merck & Co. Inc.) as the top...